CD22 CAR Optimization for Improved in-Human Activity Following Inadequate CD22 CAR Activity in Phase 1 Clinical Trial PLAT-04Corinne Summers, Rebecca Gardner, Colleen Annesley et al.|Blood|2021Cited by 9